{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:32:03Z","timestamp":1790721123423,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>\n                    Posterior fossa (PF) diffuse gliomas in pediatric patients frequently harbor the H3 K27M mutation. Among adults, PF diffuse gliomas are rare, with limited data regarding molecular features and clinical outcomes. We identified 28 adult PF diffuse glioma patients (17 males; median: 50\u2009y, range: 19 to 78\u2009y), with surgery performed at our institution (13 brainstem; 15 cerebellum). Histologic subtypes included anaplastic astrocytoma (n=21), glioblastoma (n=6), and diffuse astrocytoma (n=1). Immunohistochemistry was performed for H3 K27M (n=26), IDH1-R132H (n=28), and ATRX (n=28). A 150-gene neuro-oncology-targeted next-generation sequencing panel was attempted in 24\/28, with sufficient informative material in 15 (51.7%). Tumors comprised 4 distinct groups: driver mutations in\n                    <jats:italic toggle=\"yes\">H3F3A<\/jats:italic>\n                    (brainstem=4; cerebellum=2),\n                    <jats:italic toggle=\"yes\">IDH1<\/jats:italic>\n                    (brainstem=4; cerebellum=4),\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    promotor mutation (brainstem=0; cerebellum=3), and none of these (n=5), with the latter harboring mutations of\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PDGFRA<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ATRX<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">NF1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">RB1<\/jats:italic>\n                    . All\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    promoter\u2013mutant cases were IDH-wild-type and arose within the cerebellum. To date, 20 patients have died of disease, with a median survival of 16.3 months, 1-year survival of 67.5%. Median survival within the subgroups included:\n                    <jats:italic toggle=\"yes\">H3F3A<\/jats:italic>\n                    =16.4 months,\n                    <jats:italic toggle=\"yes\">IDH<\/jats:italic>\n                    mutant=113.4 months, and\n                    <jats:italic toggle=\"yes\">TERT<\/jats:italic>\n                    promoter mutant=12.9 months. These findings suggest that PF diffuse gliomas affecting adults show molecular heterogeneity, which may be associated with patient outcomes and possible response to therapy, and supports the utility of molecular testing in these tumors.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001690","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T20:02:19Z","timestamp":1614369739000},"page":"1082-1090","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity"],"prefix":"10.1097","volume":"45","author":[{"given":"Kathryn L.","family":"Eschbacher","sequence":"first","affiliation":[{"name":"Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane M.","family":"Ida","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Radiology"},{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Alvi","sequence":"additional","affiliation":[{"name":"Neurologic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Ruff","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kerezoudis","sequence":"additional","affiliation":[{"name":"Neurologic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Neth","sequence":"additional","affiliation":[{"name":"Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romela M.","family":"Pasion","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Daniels","sequence":"additional","affiliation":[{"name":"Neurologic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sani H.","family":"Kizilbash","sequence":"additional","affiliation":[{"name":"Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Raghunathan","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1002\/cncr.29920","article-title":"Adult brainstem gliomas","volume":"122","author":"Eisele","year":"2016","journal-title":"Cancer"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/NP301104","article-title":"Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations","volume":"37","author":"Tauzi\u00e8de-espariat","year":"2018","journal-title":"Clin Neuropathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11060-011-0704-4","article-title":"Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG","volume":"105","author":"Bartels","year":"2011","journal-title":"J Neurooncol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat Genet"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat Genet"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00432-018-02836-5","article-title":"High frequency of H3 K27M mutations in adult midline gliomas","volume":"145","author":"Ebrahimi","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2176\/nmc.oa.2019-0168","article-title":"Midline glioma in adults: clinicopathological, genetic, and epigenetic analysis","volume":"60","author":"Enomoto","year":"2020","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/nly006","article-title":"Adult brainstem gliomas with H3K27M mutation: radiology, pathology, and prognosis","volume":"77","author":"Daoud","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-019-03134-x","article-title":"Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas","volume":"143","author":"Schreck","year":"2019","journal-title":"J Neurooncol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/neuonc\/now274","article-title":"Characteristics of H3 K27M-mutant gliomas in adults","volume":"19","author":"Meyronet","year":"2017","journal-title":"Neuro Oncol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jocn.2019.11.016","article-title":"H3K27M mutation in adult cerebellar glioblastoma","volume":"71","author":"Lu","year":"2020","journal-title":"J Clin Neurosci"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2018.04.015","article-title":"H3 K27M-mutant diffuse midline gliomas in different anatomical locations","volume":"78","author":"Wang","year":"2018","journal-title":"Hum Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s41379-019-0271-3","article-title":"Spinal cord high-grade infiltrating gliomas in adults: clinico-pathological and molecular evaluation","volume":"32","author":"Alvi","year":"2019","journal-title":"Mod Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"14075","DOI":"10.1073\/pnas.1008850107","article-title":"Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres","volume":"107","author":"Lewis","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrm.2016.166","article-title":"Variants of core histones and their roles in cell fate decisions, development and cancer","volume":"18","author":"Buschbeck","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-020-02194-y","article-title":"Infratentorial IDH-mutant astrocytoma is a distinct subtype","volume":"140","author":"Banan","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/nan.12246","article-title":"Diagnostic, prognostic and predictive relevance of molecular markers in gliomas","volume":"41","author":"Brandner","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10014-017-0292-x","article-title":"Radiation-induced gliomas: a report of four cases and analysis of molecular biomarkers","volume":"34","author":"Nakao","year":"2017","journal-title":"Brain Tumor Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-018-1906-z","article-title":"The genetic landscape of gliomas arising after therapeutic radiation","volume":"137","author":"L\u00f3pez","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10014-018-0316-1","article-title":"Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia","volume":"35","author":"Kajitani","year":"2018","journal-title":"Brain Tumor Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"e2086","DOI":"10.1212\/WNL.0000000000005658","article-title":"actionable mutations, molecular specificities, and outcome of adult midline gliomas","volume":"90","author":"Picca","year":"2018","journal-title":"Neurology"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","article-title":"cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\u201d","volume":"136","author":"Brat","year":"2018","journal-title":"Acta Neuropathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bpa.12336","article-title":"Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations","volume":"26","author":"Solomon","year":"2016","journal-title":"Brain Pathol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"2012","journal-title":"Cancer Cell"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/1793-5482.228540","article-title":"IDH1 mutation in brain stem glioma: case report and review of literature","volume":"13","author":"Javadi","year":"2018","journal-title":"Asian J Neurosurg"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/NEN.0b013e31825c448a","article-title":"BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern","volume":"71","author":"Ida","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"82571","DOI":"10.18632\/oncotarget.19653","article-title":"Genetic and immune features of resectable malignant brainstem gliomas","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2015.04.014","article-title":"Adult brainstem gliomas: correlation of clinical and molecular features","volume":"353","author":"Theeler","year":"2015","journal-title":"J Neurol Sci"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-013-1312-2","article-title":"Molecular analysis of diffuse intrinsic brainstem gliomas in adults","volume":"116","author":"Reyes-botero","year":"2014","journal-title":"J Neurooncol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-012-1011-7","article-title":"Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas","volume":"124","author":"Ellezam","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00401-017-1771-1","article-title":"Distinct molecular profile of diffuse cerebellar gliomas","volume":"134","author":"Nomura","year":"2017","journal-title":"Acta Neuropathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N Engl J Med"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"E193","DOI":"10.1093\/neuros\/nyy347","article-title":"Letter: Impact of H3.3 K27M mutation on prognosis and survival of grade IV spinal cord glioma on the basis of new 2016 World Health Organization Classification of the Central Nervous System","volume":"83","author":"Lu","year":"2018","journal-title":"Neurosurgery"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","article-title":"Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation","volume":"139","author":"Castel","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-018-04448-6","article-title":"The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma","volume":"9","author":"Diplas","year":"2018","journal-title":"Nat Commun"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-019-03374-x","article-title":"The role of radiation and chemotherapy in adult patients with high-grade brainstem gliomas: results from the National Cancer Database","volume":"146","author":"Kerezoudis","year":"2020","journal-title":"J Neurooncol"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-019-0801-8","article-title":"Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities","volume":"7","author":"Reinhardt","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/neuonc\/noy123","article-title":"Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma","volume":"21","author":"Cho","year":"2019","journal-title":"Neuro Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:00:34Z","timestamp":1749405634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001690","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}